Immunoglobulin E (IgE) plays a central role in type I hypersensitivity including allergy
and asthma. Novel treatment strategy envisages development of a therapeutic vaccine designed to elicit
autologous blocking antibodies against the IgE. We sought to develop an IgE-epitope antigen that induces
antibodies against a receptor-contacting epitope on human IgE molecule